Eritromicina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eritromicina" in Italian language version.

refsWebsite

Global rank Italian rank

19nih.gov

4^th place

9^th place

4oadoi.org

799^th place

22^nd place

4doi.org

2^nd place

7^th place

3archive.org

6^th place

8^th place

1fda.gov

447^th place

644^th place

1web.archive.org

1^st place

archive.org

R. Martell, D. Heinrichs; CR. Stiller; M. Jenner; PA. Keown; J. Dupre, The effects of erythromycin in patients treated with cyclosporine., in Ann Intern Med, vol. 104, n. 5, maggio 1986, pp. 660-1, PMID 3963664.
R. Ghali, J. De Léan; Y. Douville; HP. Noël; R. Labbé, Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy., in Ann Vasc Surg, vol. 7, n. 3, Mag 1993, pp. 291-6, PMID 8391300.
K. Aranko, H. Luurila; JT. Backman; PJ. Neuvonen; KT. Olkkola, The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone., in Br J Clin Pharmacol, vol. 38, n. 4, Ott 1994, pp. 363-7, PMID 7833227.

doi.org

dx.doi.org

S. Kenyon, K. Pike; DR. Jones; P. Brocklehurst; N. Marlow; A. Salt; DJ. Taylor, Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial., in Lancet, vol. 372, n. 9646, Ott 2008, pp. 1310-8, DOI:10.1016/S0140-6736(08)61202-7, PMID 18804274.
HT. Sørensen, MV. Skriver; L. Pedersen; H. Larsen; F. Ebbesen; HC. Schønheyder, Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides., in Scand J Infect Dis, vol. 35, n. 2, 2003, pp. 104-6, DOI:10.1080/0036554021000027010, PMID 12693559.
WA. Ray, KT. Murray; S. Meredith; SS. Narasimhulu; K. Hall; CM. Stein, Oral erythromycin and the risk of sudden death from cardiac causes., in N Engl J Med, vol. 351, n. 11, Set 2004, pp. 1089-96, DOI:10.1056/NEJMoa040582, PMID 15356306.
B. Karam, E. Farah; R. Ashoush; V. Jebara; E. Ghayad, Ergotism precipitated by erythromycin: a rare case of vasospasm., in Eur J Vasc Endovasc Surg, vol. 19, n. 1, gennaio 2000, pp. 96-8, DOI:10.1053/ejvs.1999.0985, PMID 10706847.

fda.gov

Onyeka Otugo, Olabode Ogundare, Christopher Vaughan, Emmanuel Fadiran, Leyla Sahin, Consistency of Pregnancy Labeling Across Different Therapeutic Classes (PDF), su fda.gov, Food and Drug Administration - Office of Women's Health, 1979. URL consultato il 27 giugno 2013.

nih.gov

ncbi.nlm.nih.gov

R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, febbraio 1996, pp. 69-77, PMID 8852521.
S. Kenyon, K. Pike; DR. Jones; P. Brocklehurst; N. Marlow; A. Salt; DJ. Taylor, Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial., in Lancet, vol. 372, n. 9646, Ott 2008, pp. 1310-8, DOI:10.1016/S0140-6736(08)61202-7, PMID 18804274.
S. Matsuda, Transfer of antibiotics into maternal milk., in Biol Res Pregnancy Perinatol, vol. 5, n. 2, 1984, pp. 57-60, PMID 6743732.
HT. Sørensen, MV. Skriver; L. Pedersen; H. Larsen; F. Ebbesen; HC. Schønheyder, Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides., in Scand J Infect Dis, vol. 35, n. 2, 2003, pp. 104-6, DOI:10.1080/0036554021000027010, PMID 12693559.
Y. Zhang, Q. Zhang; Z. Xu, [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]., in Zhonghua Fu Chan Ke Za Zhi, vol. 32, n. 5, Mag 1997, pp. 288-92, PMID 9596854.
WA. Ray, KT. Murray; S. Meredith; SS. Narasimhulu; K. Hall; CM. Stein, Oral erythromycin and the risk of sudden death from cardiac causes., in N Engl J Med, vol. 351, n. 11, Set 2004, pp. 1089-96, DOI:10.1056/NEJMoa040582, PMID 15356306.
P. Vereerstraeten, P. Thiry; P. Kinnaert; C. Toussaint, Influence of erythromycin on cyclosporine pharmacokinetics., in Transplantation, vol. 44, n. 1, luglio 1987, pp. 155-6, PMID 3603676.
CW. Jensen, SM. Flechner; CT. Van Buren; OH. Frazier; DA. Cooley; MI. Lorber; BD. Kahan, Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin., in Transplantation, vol. 43, n. 2, febbraio 1987, pp. 263-70, PMID 3544386.
R. Martell, D. Heinrichs; CR. Stiller; M. Jenner; PA. Keown; J. Dupre, The effects of erythromycin in patients treated with cyclosporine., in Ann Intern Med, vol. 104, n. 5, maggio 1986, pp. 660-1, PMID 3963664.
M. Sands, RB. Brown, Interactions of cyclosporine with antimicrobial agents., in Rev Infect Dis, vol. 11, n. 5, pp. 691-7, PMID 2682943.
H. Francis, A. Tyndall; J. Webb, Severe vascular spasm due to erythromycin-ergotamine interaction., in Clin Rheumatol, vol. 3, n. 2, Giu 1984, pp. 243-6, PMID 6236021.
R. Ghali, J. De Léan; Y. Douville; HP. Noël; R. Labbé, Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy., in Ann Vasc Surg, vol. 7, n. 3, Mag 1993, pp. 291-6, PMID 8391300.
PA. Bird, AD. Sturgess, Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin--ergotamine drug interaction., in Aust N Z J Med, vol. 30, n. 5, ottobre 2000, pp. 635-6, PMID 11108077.
B. Karam, E. Farah; R. Ashoush; V. Jebara; E. Ghayad, Ergotism precipitated by erythromycin: a rare case of vasospasm., in Eur J Vasc Endovasc Surg, vol. 19, n. 1, gennaio 2000, pp. 96-8, DOI:10.1053/ejvs.1999.0985, PMID 10706847.
G. Lagier, A. Castot; G. Riboulet; C. Boesh, [A minor case of ergotism appearing to be connected with a potentialisation of ergotamine tartrate by erythromycine ethyl-succinate (author's transl)]., in Therapie, vol. 34, n. 4, pp. 515-21, PMID 531783.
RI. Sato, DR. Gray; SE. Brown, Warfarin interaction with erythromycin., in Arch Intern Med, vol. 144, n. 12, Dic 1984, pp. 2413-4, PMID 6508448.
K. Bachmann, JI. Schwartz; R. Forney; A. Frogameni; LE. Jauregui, The effect of erythromycin on the disposition kinetics of warfarin., in Pharmacology, vol. 28, n. 3, 1984, pp. 171-6, PMID 6718483.
JP. Phillips, EJ. Antal; RB. Smith, A pharmacokinetic drug interaction between erythromycin and triazolam., in J Clin Psychopharmacol, vol. 6, n. 5, ottobre 1986, pp. 297-9, PMID 3771812.
K. Aranko, H. Luurila; JT. Backman; PJ. Neuvonen; KT. Olkkola, The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone., in Br J Clin Pharmacol, vol. 38, n. 4, Ott 1994, pp. 363-7, PMID 7833227.

oadoi.org

S. Kenyon, K. Pike; DR. Jones; P. Brocklehurst; N. Marlow; A. Salt; DJ. Taylor, Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial., in Lancet, vol. 372, n. 9646, Ott 2008, pp. 1310-8, DOI:10.1016/S0140-6736(08)61202-7, PMID 18804274.
HT. Sørensen, MV. Skriver; L. Pedersen; H. Larsen; F. Ebbesen; HC. Schønheyder, Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides., in Scand J Infect Dis, vol. 35, n. 2, 2003, pp. 104-6, DOI:10.1080/0036554021000027010, PMID 12693559.
WA. Ray, KT. Murray; S. Meredith; SS. Narasimhulu; K. Hall; CM. Stein, Oral erythromycin and the risk of sudden death from cardiac causes., in N Engl J Med, vol. 351, n. 11, Set 2004, pp. 1089-96, DOI:10.1056/NEJMoa040582, PMID 15356306.
B. Karam, E. Farah; R. Ashoush; V. Jebara; E. Ghayad, Ergotism precipitated by erythromycin: a rare case of vasospasm., in Eur J Vasc Endovasc Surg, vol. 19, n. 1, gennaio 2000, pp. 96-8, DOI:10.1053/ejvs.1999.0985, PMID 10706847.

web.archive.org

FDA Pregnancy Categories (PDF), su depts.washington.edu. URL consultato l'11 giugno 2013 (archiviato dall'url originale il 14 dicembre 2010).